🌟 Are you ready for a transformation in pharmacoeconomic assessments?
The Dutch National Health Care Institute is set to unveil its **Pharmacoeconomic Redesign** on September 1, 2025, introducing a refined framework for evaluating drug reimbursement in the Netherlands. This innovative approach emphasizes clarity, transparency, and methodological rigor, ensuring more informed decisions in healthcare.
Dive into the article to discover how these changes will impact market access and elevate standards in health economics!
#SyenzaNews #HealthEconomics #MarketAccess